Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).

The global recommendation – issued Monday at the International AIDS Conference in Kigali, Rwanda – comes about a month after ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

In a session titled, Better meeting the needs of people living with HIV, health experts reminded us that science, care, and human rights must move together if we are to achieve real change.